Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04847102 |
|---|---|
| Brief Title: | A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above |
| First Submitted : | April 13, 2021 |
| First Submitted that Met QC Criteria : | April 13, 2021 |
| First Posted : | April 15, 2021 |
| Last Update Submitted that Met QC Criteria : | November 10, 2021 |
| Last Update Posted : | November 18, 2021 |